Tag: Janssen Research & Development

Xarelto

Xarelto (rivaroxaban) reduces risk of major amputation by 70% in peripheral...

Bayer and its cooperation partner Janssen Research & Development have announced two publications of further data from the Phase III COMPASS study in The...